ChemicalsMid capRs 9,822 crRs 12.4 cr traded a day
Close on 10 September 2026
1,920.30
−1.24%
52-week range80% of the way up
1,231.602,089.60
Market cap
9,822 cr
P/E (TTM)
43.6×
industry 36×
EPS (TTM)
44.03
Revenue YoY
+30.2%
Q1 FY27
Profit YoY
+91.4%
Net margin
17.9%
+5.7pt vs a year ago
Growth trend
+30.0pt
vs last quarter’s YoY
1 month
+1.6%
Below 52w high
8.8%
RSI (14)
32
Daily swing
3.6%
average true range
Volume
0.5×
vs 20-day average
Traded
Rs 12 cr
median day
Close200-day averageMaterial filing
260 sessions · hover for the filing behind a move
Key metrics
each ranked against every stock scanned tonight
Above the 200-day average
Above the median
+16.2%
One-year return
Around the median
-5.3%
Return on capital employed
n/a
Debt to equity
n/a
Profitable quarters, last four
of the last four reported
4 of 4
Cash conversion
cash from operations against reported profit
n/a
Revenue growth, year on year
latest reported quarter
+30.2%
Below the 52-week high
from the highest close of the year
-8.1%
1 week
−4.14%
1 month
+1.61%
3 months
+5.81%
6 months
+42.23%
1 year
−5.31%
The read
written from the numbers on this page
The evidence leans constructive6 supporting, 2 against, 0 worth knowing
Supporting
trading 16% above its 200-day average
matches growing fast, sold off anyway, which has beaten the market by +1.11 points over 20 sessions across 29,180 past signals
9 of the scans it matches have a positive measured record
4 independent kinds of evidence agree today, which is uncommon
revenue grew 30% year on year in the quarter ending 30 June 2026
net margin has widened from 11.0% to 17.9% across four quarters
Against
down 5% over twelve months
priced at 44× earnings against an industry median of 36× — 21% above its peers
Worth knowing
nothing the data supports either way
What would change this read: a close below 1,653, its 200-day average.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
What is working, what is not
from the filings and from the price, with the figure behind every line
Working5
Net profit rose 91.4% year on year, from Rs 49 cr to Rs 95 cr.
+91.4%Rs 49 crRs 95 cr
Profit grew faster than revenue, +91.4% against +30.2%.
+91.4%+30.2%
Net margin improved from 12.2% to 17.9%.
12.2%17.9%
Trading 16.2% above its 200-day average, which is the line most investors use to separate a bull phase from a bear one.
+16.2%
3 different kinds of evidence point at it tonight, not 3 versions of the same one.
3 families
Needs watching
Nothing on this side tonight — not in the filings and not in the price.
Every figure here is computed — from the company’s own filings, or from its own closing prices. Wording of 3 of these 3 filing lines was drafted by a language model, which is given the figures and may not introduce another — any sentence containing a number that did not come from the filings is discarded before it reaches this page.
How it has performed
price return over each window, beside the median NSE stock over the same days
What the scans say today
11 of 47 matched on 10 Sep
ALKYLAMINE matches 11 of the 47 scans today, across 4 different kinds of evidence. Three or more independent families agreeing is uncommon — it is the same test the shortlist on every page uses.
ALKYLAMINE trades at 44× trailing earnings, below its median of 51× over this window — 14% less expensive than usual. The band runs from the 5th to the 95th percentile, so single-day spikes do not set the edges.
This window is short by the standards of valuation history — it begins where four quarters of filed earnings first exist. A stock can look cheap against two years and expensive against ten.
AGM / EGM filings were typically +0.17pt vs the market over the next 5 sessions (n=8,423)
The business
from the company’s filed results
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.
Going for it
revenue grew 30% against the same quarter a year earlier
profit rose 91% year on year
net margin widened from 11.7% to 17.9%
Going against it
nothing clear in the filed numbers
Quarter-by-quarter numbers, as filed
Quarter
Revenue
Profit before tax
Net profit
EPS
Net margin
Q1 FY27
30 Jun · standalone
528
125
95
18.50
17.9%
Q4 FY26
31 Mar · standalone
387
61
45
8.87
11.7%
Q3 FY26
31 Dec · standalone
354
57
42
8.26
11.9%
Q2 FY26
30 Sep · standalone
389
59
43
8.40
11.0%
Q1 FY26
30 Jun · standalone
406
66
49
9.67
12.2%
Q4 FY25
31 Mar · standalone
386
59
46
9.00
11.9%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average+0.3%
Versus 200-day average+16.2%
Below 52-week high-8.1%
Above 52-week low+55.9%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)31.7
Higher closes in last 51 of 5
Six-month return+42.23%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.
Typical daily swing (ATR)3.56%
Volume versus 20-day0.5x
Median daily turnoverRs 12.4 cr
Peers
Chemicals · 44 classified companies
ALKYLAMINE trades at 43.6× trailing earnings against an industry median of 36.0× across 41 other classified companies in its industry — more expensive than them, by 21%. A multiple is a statement about expectations, not about quality: cheap usually means the market expects less, and it is often right.
largest twelve by market capitalisation. Market cap and P/E need filed financials, so blanks are companies whose filings have not been read yet
Recent sessions
what this stock has matched since the engine went live
This is the live record, not the backtest — the scans this stock actually appeared in on each stored session. A name that keeps reappearing is in a persistent condition; a one-day appearance usually is not.